Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Zhu

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Structure (London, England : 1993)|July 18, 2006
Domain-swapped structure of the potent antiviral protein griffithsin and its mode of carbohydrate bindingNatasza E Ziółkowska, Barry R O'Keefe, Toshiyuki Mori, et al.
Oncotarget|April 28, 2016
Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancerTakahiro Yoshida, Kideok Jin, Hong Song, et al.
Cancer Research|May 2, 2025
Correction: Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 FunctionShawn J Macha, Balakrishna Koneru, Trevor A Burrow, et al.
Cancer Research|August 10, 2022
Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 FunctionShawn J Macha, Balakrishna Koneru, Trevor A Burrow, et al.
Environmental Science & Technology|December 24, 2011
Methodology of metal criticality determinationT E Graedel, Rachel Barr, Chelsea Chandler, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Structure (London, England : 1993)|July 18, 2006
Domain-swapped structure of the potent antiviral protein griffithsin and its mode of carbohydrate bindingNatasza E Ziółkowska, Barry R O'Keefe, Toshiyuki Mori, et al.
Oncotarget|April 28, 2016
Effective treatment of ductal carcinoma in situ with a HER-2- targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancerTakahiro Yoshida, Kideok Jin, Hong Song, et al.
Cancer Research|May 2, 2025
Correction: Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 FunctionShawn J Macha, Balakrishna Koneru, Trevor A Burrow, et al.
Cancer Research|August 10, 2022
Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 FunctionShawn J Macha, Balakrishna Koneru, Trevor A Burrow, et al.
Environmental Science & Technology|December 24, 2011
Methodology of metal criticality determinationT E Graedel, Rachel Barr, Chelsea Chandler, et al.
Pageof 2